EperezolidAlternative Names: PNU 100592; U 100592
Latest Information Update: 18 Sep 2001
At a glance
- Originator Pharmacia Corporation
- Class Acetamides; Antibacterials; Oxazolidinones; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Gram-positive infections